[Survival Analysis of Stage I Non-small Cell Lung Cancer Patients Treated with 
Da Vinci Robot-assisted Thoracic Surgery].

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published Date: Nov 20, 2018

Abstract

BACKGROUND: Da Vinci robotic surgery system is widely used in department of thoracic surgery. The aim of this study is to investigate the treatment outcome of stage I non-small cell lung cancer (NSCLC) via da Vinci Surgical System.

Authors

  • Xingchi Liu
    Department of Thoracic Surgery, General Hospital of Shenyang Military Command, Shenyang 110016, China.
  • Shiguang Xu
    Department of Thoracic Surgery, General Hospital of Shenyang Military, Shenyang 110015, China.
  • Bo Liu
    Wuhan United Imaging Healthcare Surgical Technology Co., Ltd., Wuhan, China.
  • Wei Xu
    College of Food and Bioengineering, Henan University of Science and Technology, Luoyang, 471023 China.
  • Renquan Ding
    Department of Thoracic Surgery, General Hospital of Shenyang Military, Shenyang 110015, China.
  • Tong Wang
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China; Key Laboratory of Coal Environmental Pathogenicity and Prevention (Shanxi Medical University), Ministry of Education, Taiyuan 030000, China.
  • Bo Li
    Electric Power Research Institute, Yunnan Power Grid Co., Ltd., Kunming, Yunnan, China.
  • Xilong Wang
    Department of Thoracic Surgery, General Hospital of Shenyang Military Command, Shenyang 110016, China.
  • Qiong Wu
    Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, P. R. China.
  • Hong Teng
    Department of Thoracic Surgery, General Hospital of Shenyang Military Command, Shenyang 110016, China.
  • Shumin Wang
    Department of Thoracic Surgery, General Hospital of Shenyang Military, Shenyang 110015, China.

Keywords

External Resources

Popular Topics
Recent Journals